Article

Splose, an allied health software platform from Adelaide, has raised $46 million in Series A funding, marking a record for South Australian SaaS businesses. Led by Spectrum Equity, with participation from Athletic Ventures, the new funding follows a $5 million round in 2025.

Splose's software serves over 20,000 practitioners and has experienced over 100% year-on-year growth. The company is focused on expanding in the UK, where it has seen a 300% growth since its entry 18 months ago. The capital will enhance product development and AI integration across its platform, offering features like transcription and workflow automation.